The irbesartan market is estimated at USD 72.5 million in 2026, is projected to reach USD 120.4 million by 2036 and is forecast to register a 5.2% CAGR between 2026 and 2036. In 2026, powder holds 83.0% within the form segment and ≥99.5% represents 62.0% of the purity grade category.